Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
114.99
-1.00 (-0.86%)
Mar 4, 2025, 3:37 PM EST - Market open
Gilead Sciences Stock Forecast
Stock Price Forecast
The 25 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 102.96, with a low estimate of 69 and a high estimate of 132. The average target predicts a decrease of -10.46% from the current stock price of 114.99.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gilead Sciences stock from 27 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 4 | 4 |
Buy | 8 | 10 | 11 | 12 | 12 | 12 |
Hold | 10 | 12 | 12 | 11 | 11 | 11 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 24 | 26 | 26 | 27 | 27 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy Maintains $115 → $132 | Buy | Maintains | $115 → $132 | +14.79% | Mar 4, 2025 |
Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $80 → $120 | Hold → Strong Buy | Upgrades | $80 → $120 | +4.36% | Feb 18, 2025 |
RBC Capital | RBC Capital | Hold Maintains $84 → $90 | Hold | Maintains | $84 → $90 | -21.73% | Feb 12, 2025 |
Goldman Sachs | Goldman Sachs | Hold Maintains $85 → $96 | Hold | Maintains | $85 → $96 | -16.51% | Feb 12, 2025 |
BMO Capital | BMO Capital | Buy Maintains $110 → $115 | Buy | Maintains | $110 → $115 | +0.01% | Feb 12, 2025 |
Financial Forecast
Revenue This Year
29.25B
from 28.75B
Increased by 1.72%
Revenue Next Year
30.28B
from 29.25B
Increased by 3.51%
EPS This Year
8.08
from 0.38
Increased by 2,026.80%
EPS Next Year
8.44
from 8.08
Increased by 4.37%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 30.3B | 32.8B | 35.1B | ||
Avg | 29.2B | 30.3B | 31.6B | ||
Low | 27.9B | 27.7B | 28.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 5.5% | 12.1% | 15.9% | ||
Avg | 1.7% | 3.5% | 4.5% | ||
Low | -2.8% | -5.3% | -4.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 8.56 | 9.53 | 10.86 | ||
Avg | 8.08 | 8.44 | 8.91 | ||
Low | 7.60 | 5.33 | 5.03 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2,152.0% | 18.0% | 28.7% | ||
Avg | 2,026.8% | 4.4% | 5.6% | ||
Low | 1,901.3% | -34.0% | -40.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.